Gilead Sciences Inc (GILD)

69.38
+0.45(+0.65%)
  • Volume:
    2,367,176
  • Bid/Ask:
    69.37/69.38
  • Day's Range:
    68.73 - 69.89

GILD Overview

Prev. Close
68.93
Day's Range
68.73-69.89
Revenue
25.56B
Open
68.9
52 wk Range
56.56-73.85
EPS
0.21
Volume
2,367,176
Market Cap
87.32B
Dividend (Yield)
2.84
(4.13%)
Average Vol. (3m)
6,756,486
P/E Ratio
335.02
Beta
0.41
1-Year Change
-7.53%
Shares Outstanding
1,254,178,166
Next Earnings Date
Jul 29, 2021
What is your sentiment on Gilead Sciences Inc?
or
Vote to see community's results!

Gilead Sciences Inc News

Gilead Sciences Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong SellStrong BuyStrong BuyStrong BuyBuy
SummarySellStrong BuyStrong BuyStrong BuyBuy

Gilead Sciences Inc Company Profile

Gilead Sciences Inc Company Profile

Employees
13600

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California.

Read More
  • The pre-timing chart would be abreath of fresh air -https://www.pretiming.com/search/label/GILD%20stock%20forecast
    0
    • Today is dividend day, but stock price is going down.
      2
      • classic value trap
        2
        • this stock **** been around 65 for over a year. wth.
          0
          • pretty solid dividend, though
            0
        • look at Regeneron, on Squawk Ally. Twice the reporter came at him in two different way about cost and every day people being able to receive their drug and their CFO refused to address the affordable of their drug, he said it's up to doctors, the states, and the government to ensure they get the best possible treatment for people.
          3
          • Gild was never trash... just weak management at the point of attack. Rendeservir (forgive my spelling) is still the most used therapeutic out there.. Every person I've known who contracted Covid-19 have been treated in the hospital around here and in South Fla with it... leadership should of capitalized on the foundation they built... just my 2 cents
            0
            • let's go. lets see 60 today!
              8
              • $78 by End of next week?! Agree?
                3
                • But if Gilead keeps pumping out cures for diseases maybe i will live to see 2090.
                  0
                • How you can know it?
                  0
                • Jack Lee :)))
                  0
              • most solid investment right now
                1
                • yes, eat your money slowly
                  5
                • Jack Leei hope you didnt short at $58 because then you will have been eating your money slowly. Looser
                  0
              • It looks like its not going anywhere, but it’s solid investment
                3
                • man. thus stock is crazy
                  1
                  • PharmaMar's antiviral is 100 times more effective against Covid-19 than other treatments, reducing its viral load by almost 100%
                    0
                    • Gilead is a good share .  will go higher for sure.!
                      2
                      • https://invst.ly/tqicz
                        1
                        • https://invst.ly/tr34y
                          0
                        • https://invst.ly/tr4ab
                          0
                      • I think we should see $84 by June this year, but I don’t think it’s going be higher until they start to get profits from new cancer drugs. Anyway, probably next year can be game changer for the stock.
                        1
                        • Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial - Reuters. I guess pfizer doesnt care about Indians well being... or the vacine is a fraud. Dont worry gilead gave them Veklury. Thanks but no thanks Pfizer.
                          1
                          • when is the dividend date?
                            3
                            • Guys and girls, what did I said? 2021 gonna be the beginning of strong moving year for Gilead, hop on the train now before it’s gonna be late.
                              0
                              • EPS earning good!
                                0
                                • $75 next week
                                  1
                                  • The conference call is at 430pm but when is the earning release?
                                    0
                                    • during the conference
                                      0
                                  • Great news https://finance.yahoo.com/news/gilead-sciencess-earnings-outlook-151440708.html Remenber after earnings often stock flet but by the half of february the stock will reach 75 usd and dont forget MORGAN STANLEY 83 usd TARGET https://www.barrons.com/articles/2-reasons-this-will-be-gileads-year-says-morgan-stanley-51611082220
                                    1
                                    • This is worse than watching KHC
                                      0
                                      • lol, this stock sacks
                                        9
                                        • Thank you Morgan Stanley to 83
                                          1
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.